OpenURL Connection Search

Select item for more details and to access through your institution.

Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients.
Published in:
Supportive Care in Cancer, 2024, v. 32, n. 6, p. 1, doi. 10.1007/s00520-024-08564-6
By:
- Kraehenbuehl, L.;
- Kang, D.;
- Bang, A. S.;
- Ketosugbo, K. F.;
- Hay, J.;
- Patil, Sujata;
- Goldfarb, S.;
- Cho, J.;
- Lacouture, M. E.
Publication type:
Article
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers.
Published in:
Investigational New Drugs, 2021, v. 39, n. 3, p. 785, doi. 10.1007/s10637-020-01035-9
By:
- Wu, J.;
- Liu, D.;
- Offin, M.;
- Lezcano, C.;
- Torrisi, J. M.;
- Brownstein, S.;
- Hyman, D. M.;
- Gounder, M. M.;
- Abida, W.;
- Drilon, A.;
- Harding, J. J.;
- Sullivan, R. J.;
- Janku, F.;
- Welsch, D.;
- Varterasian, M.;
- Groover, A.;
- Li, B. T.;
- Lacouture, M. E.
Publication type:
Article
A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension.
Published in:
Clinical Pharmacology & Therapeutics, 2010, v. 87, n. 3, p. 303, doi. 10.1038/clpt.2009.217
By:
- Gomberg-Maitland, M.;
- Maitland, M. L.;
- Barst, R. J.;
- Sugeng, L.;
- Coslet, S.;
- Perrino, T. J.;
- Bond, L.;
- LaCouture, M. E.;
- Archer, S. L.;
- Ratain, M. J.
Publication type:
Article
Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib.
Published in:
2008
By:
- Rosenbaum SE;
- Wu S;
- Newman MA;
- West DP;
- Kuzel T;
- Lacouture ME;
- Rosenbaum, S E;
- Wu, S;
- Newman, M A;
- West, D P;
- Kuzel, T;
- Lacouture, M E
Publication type:
journal article
Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 5, p. 720, doi. 10.1111/jdv.14612
By:
- Shah, V. V.;
- Wikramanayake, T. C.;
- Delcanto, G. M.;
- Van Den Hurk, C.;
- Wu, S.;
- Lacouture, M. E.;
- Jimenez, J. J.
Publication type:
Article
Granuloma annulare associated with immune checkpoint inhibitors.
Published in:
2018
By:
- Lacouture, M. E.;
- Wu, J.;
- Chung, W. H.;
- Kwong, B. Y.;
- Martires, K. J.;
- Rieger, K. E.;
- Iyer, G. V.
Publication type:
Case Study
Olmutinib‐induced palmoplantar keratoderma.
Published in:
British Journal of Dermatology, 2018, v. 178, n. 2, p. e129, doi. 10.1111/bjd.15935
By:
- Chen, K. L.;
- Cho, Y. T.;
- Yang, C. W.;
- Sheen, Y. S.;
- Liang, C. W.;
- Lacouture, M. E.;
- Chu, C. Y.
Publication type:
Article
The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome.
Published in:
2006
By:
- Lacouture, M. E.;
- Lai, S. E.
Publication type:
Letter
The microbial flora of clinically infected cutaneous metastases: a retrospective study.
Published in:
Clinical & Experimental Dermatology, 2020, v. 45, n. 6, p. 722, doi. 10.1111/ced.14241
By:
- Virgen, C. A.;
- Barker, C. A.;
- Lacouture, M. E.
Publication type:
Article
Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.
Published in:
Clinical & Experimental Dermatology, 2016, v. 41, n. 1, p. 8, doi. 10.1111/ced.12694
By:
- Belum, V. R.;
- Serna‐Tamayo, C.;
- Wu, S.;
- Lacouture, M. E.
Publication type:
Article
Higher severity grade of erlotinib-induced rash is associated with lower skin phototype.
Published in:
Clinical & Experimental Dermatology, 2011, v. 36, n. 7, p. 733, doi. 10.1111/j.1365-2230.2011.04117.x
By:
- Luu, M.;
- Boone, S. L.;
- Patel, J.;
- Sullivan, P.;
- Rademaker, A. W.;
- Balagula, Y.;
- Lacouture, M. E.
Publication type:
Article
Magnetic resonance imaging of paronychia induced by cetuximab.
Published in:
2009
By:
- Konheim, A.;
- Brebach, E.;
- Samuel, J.;
- Mellott, A.;
- Gandhi, M.;
- Lacouture, M. E.
Publication type:
Letter
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.
Published in:
Clinical & Experimental Dermatology, 2006, v. 31, n. 6, p. 783, doi. 10.1111/j.1365-2230.2006.02223.x
By:
- Lacouture, M. E.;
- Desai, A.;
- Soltani, K.;
- Petronic-Rosic, V.;
- Laumann, A. E.;
- Ratain, M. J.;
- Stadler, W. M.
Publication type:
Article
Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
Published in:
Clinical & Experimental Dermatology, 2005, v. 30, n. 1, p. 46, doi. 10.1111/j.1365-2230.2004.01659.x
By:
- Lacouture, M. E.;
- Baron, J. M.;
- Jani, A. B;
- Laumann, A. E;
- Soltani, K
Publication type:
Article

Found: 14